Insider trades
Versant Vantage II, 10% Owner of Lenz Therapeutics LENZ, has filed 4 purchases and 36 sales on the open market. The latest trade was on 25/09/30.
Versant Vantage II
10% Owner
- Company
- Lenz Therapeutics LENZ
- First filing
- 23/07/27
- Trades
- 68 trades
- Buys / sales
- 4 / 36
- 12-month net buying
- No record
- Last trade
- 25/09/30
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
LENZ | Open-market sale | 25/09/30 | 25/10/02 | 224,974 sh6 trades | $46.01avg. | $10,352,070.98 | No record |
LENZ | Open-market sale | 25/09/18 | 25/09/22 | 135,304 sh6 trades | $42.23avg. | $5,714,064.91 | No record |
LENZ | Open-market sale | 25/08/22–25/08/26 | 25/08/26 | 188,094 sh12 trades | $39.47avg. | $7,423,963.67 | No record |
LENZ | Open-market sale | 25/08/15–25/08/18 | 25/08/19 | 260,713 sh4 trades | $39.34avg. | $10,255,193.28 | No record |
| Open-market sale | 25/07/10 | 25/07/14 | 191,376 sh | $34.00 | $6,506,784 | −10.8% | |
| Open-market sale | 25/06/27 | 25/07/01 | 200,000 sh | $30.47 | $6,094,000 | −10.2% | |
LENZ | Open-market sale | 25/06/18–25/06/20 | 25/06/20 | 334,801 sh3 trades | $30.19avg. | $10,107,817.95 | No record |
| Open-market sale | 25/06/10 | 25/06/12 | 350,000 sh | $29.00 | $10,150,000 | −21.9% | |
TPST | Open-market sale | 24/08/08–24/08/12 | 24/08/12 | 787,999 sh2 trades | $1.23avg. | $966,798.9 | −79.0% |
| Open-market buy | 23/07/25 | 23/07/27 | 225,000 sh4 trades | $12.00avg. | $2,700,000 | No record |
